
About Eicos Sciences
Eicos Sciences is a Healthcare company based in San Mateo (United States) founded in 2016. It develops Prostacyclin-based therapies for underserved medical conditions globally. It operates on a B2B model. The company has 9 employees. Its website eicossciences.com draws about 681 thousand monthly visits. Eicos Sciences offers products and services including Prostacyclin Analogues. Its focus areas include Biotechnology, Therapeutics and Prostacyclin Development. Its legal entity is CIVI BIOPHARMA, INC. Its competitors include Castle Creek Biosciences and LifeMax; 1 of its 2 listed competitors has raised funding.
Company details
Eicos Sciences is a biotechnology company focused on researching and developing Prostacyclin analogues, which act as vasodilators with antiplatelet and anti-inflammatory properties. The company targets debilitating conditions like frostbite, systemic sclerosis, and ECMO, where treatment options are scarce. Based in San Mateo, California, it operates as a subsidiary of CiVi Biopharma Holding Corp., aiming to improve patient outcomes through innovative science and therapeutic pipelines.
- Headquarters San Mateo, United States
- Employees 9
- SectorsHealthcare
- Website eicossciences.com
- Legal Name Civi Biopharma, Inc.
- Employee Count9
Products & Services of Eicos Sciences
Eicos Sciences offers a comprehensive portfolio of products and services, including Prostacyclin Analogues.
Develops drugs targeting vasodilation and inflammation for rare diseases.
Competitors of Eicos Sciences
Eicos Sciences has 2 listed competitors in our database, 1 of them funded. They include Castle Creek Biosciences and LifeMax.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| castlecreekbio.com | 2018 | Exton, United States | $192.8M | 41 | Gene therapy platform for rare disease treatments is developed. | |
| lifemaxlabs.com | 2014 | Redwood, United States | Develops innovative therapeutic solutions for Netherton syndrome treatment. |
Detailed competitors of Eicos Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Eicos Sciences
The website of Eicos Sciences (eicossciences.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Eicos Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Eicos Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
3 companies that operate in the same segment as Eicos Sciences (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eicos Sciences
Complete news archive for Eicos Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eicos Sciences
Eicos Sciences was founded in 2016.
Eicos Sciences is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Eicos Sciences has 9 employees.
Eicos Sciences is a biotechnology company focused on researching and developing Prostacyclin analogues, which act as vasodilators with antiplatelet and anti-inflammatory properties. The company targets debilitating conditions like frostbite, systemic sclerosis, and ECMO, where treatment options are scarce. Based in San Mateo, California, it operates as a subsidiary of CiVi Biopharma Holding Corp., aiming to improve patient outcomes through innovative science and therapeutic pipelines.
Eicos Sciences's top competitors include Castle Creek Biosciences and LifeMax.
Eicos Sciences offers Prostacyclin Analogues.
Eicos Sciences operates through Civi Biopharma, Inc..
The website of Eicos Sciences receives about 681 thousand visits a month.
